Achieng, Florence
Rosen, Joseph G.
Cherop, Reuben Yego
Kariuki, Simon
Hoffman, Stephen L.
Seder, Robert
Oneko, Martina
Steinhardt, Laura C. http://orcid.org/0000-0003-0540-9940
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 7 November 2019
Accepted: 17 June 2020
First Online: 24 June 2020
Ethics approval and consent to participate
: Ethical approval for the study was obtained from the Kenya Medical Research Institute’s Scientific and Ethics Review Unit (study #108/3588) (Kisumu, Kenya) and received human subjects ethical clearance from the U.S. Centers for Disease Control and Prevention (Atlanta, GA, USA). Participants provided informed consent prior to data collection. Due to high levels of illiteracy in the study communities, participants incapable of providing written informed consent were verbally guided through the study consent procedures and indicated their consent with a fingerprint.
: Not applicable.
: SL. Hoffman developed the PfSPZ Vaccine referenced in the trial. Neither S.L. Hoffman nor Sanaria, Inc. played a direct role in the design, implementation, or interpretation of study findings presented in the current manuscript.